Wound Additives in Primary Total Joint Athroplasty

Arthroplasty, Replacement Clinical Trial

Official title: The Effects of Platelet-Rich Plasma and Activated Collagen on Wound Healing in Primary Total Joint Arthroplasty

Status Completed

Clinical Trial Summary

3 cohorts of total joint patient of 30 members each were randomized to receive PRP or Activated Collegen or no additive were studied for status of the wound at 6 weeks and recorded all complications, infections and reoperations. The three groups were than compared for statistical analysis

Clinical Trial Description

Background: Wound healing remains a concern in primary total joint arthroplasty given the risk of deep infections arising from hematomas, wound separations, and superficial infections. If wound additives can prevent these early complications, their universal application would be cost effective. This study examined whether two wound additives, Platelet-Rich Plasma (PRP) and CellerateRX® (activated collagen), would improve postoperative wound healing and reduce complications in primary total joint arthroplasty.

Methods: A prospective, randomized, controlled study using three cohorts with 30 patients each (Group 1: PRP, Group 2: activated collagen, Group 3: control) were examined postoperatively at two and six weeks, at which time the following data were recorded: six wound measurements, total postoperative blood loss, complications of superficial infections, and reoperations. ;

Related Conditions & MeSH terms

• Arthroplasty, Replacement

• NCT number: NCT03158623
• Study type: Interventional
• Source: Salt Lake Orthopedic Clinic
• Status: Completed
• Phase: Phase 3
• Start date: April 1, 2016
• Completion date: December 20, 2016